Benjamin E. Blass

1.4k total citations
80 papers, 978 citations indexed

About

Benjamin E. Blass is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Benjamin E. Blass has authored 80 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 29 papers in Organic Chemistry and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Benjamin E. Blass's work include Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Benjamin E. Blass is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Benjamin E. Blass collaborates with scholars based in United States, India and Canada. Benjamin E. Blass's co-authors include Domenico Praticò, Jianguo Li, Magid Abou‐Gharbia, David E. Portlock, Andrew S. Kende, Daniel J. Canney, John M. Janusz, Shengde Wu, Antonio Di Meco and Douglas A. Pippin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biological Psychiatry and Journal of Medicinal Chemistry.

In The Last Decade

Benjamin E. Blass

80 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin E. Blass United States 17 468 368 115 111 96 80 978
Pedro Besada Spain 20 388 0.8× 439 1.2× 76 0.7× 95 0.9× 53 0.6× 50 964
Bertrand Le Bourdonnec United States 16 511 1.1× 489 1.3× 255 2.2× 92 0.8× 97 1.0× 38 1.0k
Маргарита Е. Неганова Russia 20 290 0.6× 708 1.9× 67 0.6× 191 1.7× 119 1.2× 103 1.4k
Ghilsoo Nam South Korea 17 373 0.8× 394 1.1× 95 0.8× 103 0.9× 95 1.0× 52 785
Kumi Sato Japan 14 292 0.6× 205 0.6× 75 0.7× 79 0.7× 216 2.3× 39 930
Salvatore Bongarzone United Kingdom 16 157 0.3× 315 0.9× 42 0.4× 55 0.5× 118 1.2× 39 921
Aliaa Abdelrahman Germany 21 246 0.5× 442 1.2× 108 0.9× 47 0.4× 48 0.5× 38 1.0k
Alan D. Robertson United Kingdom 17 205 0.4× 405 1.1× 138 1.2× 173 1.6× 259 2.7× 31 887
Stefania Baraldi Italy 18 370 0.8× 398 1.1× 103 0.9× 116 1.0× 67 0.7× 29 906
Hazel J. Dyke United Kingdom 20 382 0.8× 468 1.3× 64 0.6× 170 1.5× 84 0.9× 30 911

Countries citing papers authored by Benjamin E. Blass

Since Specialization
Citations

This map shows the geographic impact of Benjamin E. Blass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin E. Blass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin E. Blass more than expected).

Fields of papers citing papers by Benjamin E. Blass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin E. Blass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin E. Blass. The network helps show where Benjamin E. Blass may publish in the future.

Co-authorship network of co-authors of Benjamin E. Blass

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin E. Blass. A scholar is included among the top collaborators of Benjamin E. Blass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin E. Blass. Benjamin E. Blass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Xiaoying, Xiang‐Yang Ye, Tian Xie, et al.. (2023). Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis. Medicinal Research Reviews. 43(4). 872–896. 31 indexed citations
3.
Blass, Benjamin E., et al.. (2022). Antifungal properties of (2S, 4R)-Ketoconazole sulfonamide analogs. PubMed. 2. 1 indexed citations
4.
5.
Dürig, Thomas, et al.. (2022). Development of an amorphous based sustained release system for apremilast a selective phosphodiesterase 4 (PDE4) inhibitor. International Journal of Pharmaceutics. 615. 121516–121516. 7 indexed citations
6.
Blass, Benjamin E., et al.. (2021). Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening. Journal of Chemical Information and Modeling. 61(2). 1020–1032. 31 indexed citations
7.
Chen, Peng-Jen, Michelle Taylor, Suzy A. Griffin, et al.. (2019). Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 29(18). 2690–2694. 15 indexed citations
8.
Blass, Benjamin E., Pravin S. Iyer, Magid Abou‐Gharbia, et al.. (2016). Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome. Bioorganic & Medicinal Chemistry Letters. 26(23). 5825–5829. 10 indexed citations
9.
Meco, Antonio Di, Jianguo Li, Benjamin E. Blass, et al.. (2016). 12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice. Biological Psychiatry. 81(2). 92–100. 66 indexed citations
10.
Chu, Jin, Phillip F. Giannopoulos, Benjamin E. Blass, et al.. (2015). Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice. Molecular Psychiatry. 20(11). 1329–1338. 35 indexed citations
11.
Scimia, Maria Cecilia, Benjamin E. Blass, & Walter J. Koch. (2014). Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy. Expert Review of Cardiovascular Therapy. 12(6). 733–741. 10 indexed citations
12.
Blass, Benjamin E.. (2014). Pyrimidinylpiperdinyloxypyridone Analogues as GPR119 Modulators. ACS Medicinal Chemistry Letters. 5(5). 458–459. 3 indexed citations
13.
McDonnell, Mark E., Matthew D. Vera, Benjamin E. Blass, et al.. (2012). Riluzole prodrugs for melanoma and ALS: Design, synthesis, and in vitro metabolic profiling. Bioorganic & Medicinal Chemistry. 20(18). 5642–5648. 24 indexed citations
14.
Cassel, Joel, Benjamin E. Blass, Allen B. Reitz, & Aaron C. Pawlyk. (2010). Development of a Novel Nonradiometric Assay for Nucleic Acid Binding to TDP-43 Suitable for High-Throughput Screening Using AlphaScreen® Technology. SLAS DISCOVERY. 15(9). 1099–1106. 24 indexed citations
15.
Blass, Benjamin E., Andrew Fensome, Eugene J. Trybulski, et al.. (2009). Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia. Journal of Medicinal Chemistry. 52(21). 6531–6534. 16 indexed citations
16.
Jackson, C. M., Benjamin E. Blass, Gina M. Fadayel, et al.. (2006). Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias. Bioorganic & Medicinal Chemistry Letters. 17(1). 282–284. 32 indexed citations
17.
Wu, Shengde, John M. Janusz, Benjamin E. Blass, et al.. (2006). Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(22). 5859–5863. 31 indexed citations
18.
Wu, Shengde, John M. Janusz, Benjamin E. Blass, et al.. (2006). Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(24). 6213–6218. 49 indexed citations
19.
Blass, Benjamin E., et al.. (2000). Parallel synthesis and evaluation of N-(1-phenylethyl)-5-phenyl-imidazole-2-amines as Na+/K+ ATPase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(14). 1543–1545. 11 indexed citations
20.
Blass, Benjamin E., et al.. (1999). A facile KF/Al2O3 mediated method for the synthesis of substituted oxazolidinones. Tetrahedron Letters. 40(36). 6545–6547. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro Besada Breakdown of academic impact, for papers by Bertrand Le Bourdonnec Breakdown of academic impact, for papers by Маргарита Е. Неганова Breakdown of academic impact, for papers by Ghilsoo Nam Breakdown of academic impact, for papers by Kumi Sato Breakdown of academic impact, for papers by Salvatore Bongarzone Breakdown of academic impact, for papers by Aliaa Abdelrahman Breakdown of academic impact, for papers by Alan D. Robertson Breakdown of academic impact, for papers by Stefania Baraldi Breakdown of academic impact, for papers by Hazel J. Dyke
Rankless by CCL
2026